Fatty liver disease, or hepatic steatosis, is a buildup of fat in the liver. This makes it harder for the liver to work. It is also known by other names: NAFLD (Non-alcoholoic fatty liver disease) and NASH (Non-alcoholic steatohepatitis). Some forms of fatty liver disease can lead to cirrhosis (scarring of the liver), and increase risk for developing liver cancer. While excess alcohol consumption is a major risk factor, most people who develop fatty liver disease have excess body weight.
Most patients with fatty liver disease manifest no symptoms, and are unaware that they have it. Progression to cirrhosis may result in: tiredness, swollen abdomen, enlargement of blood vessels underneath the skin, jaundice (yellowish tint of skin and eyes). Associated medical conditions include high blood fat levels, either triglycerides or LDL (“bad”) cholesterol, diabetes or prediabetes, and high blood pressure.
Although there are currently no medications for fatty liver disease, research to find a cure is underway. Meanwhile mainstay treatment options include: limiting alcohol consumption, lifestyle changes, weight reduction.